Vor Bio to Join Wells Fargo, Citi and Other September Conferences

Conexeu Sciences announced participation in the Nasdaq/LD Micro Summit Series on Sept. 9, a presentation and one-on-one meetings at a New York event Sept. 14–16, and H.C. Wainwright’s 2026 Biotech on Tap in Munich Oct. 1–3 as it advances its tissue-restoration platform. Vor Bio outlined plans to participate in multiple September healthcare investor conferences with live webcasts, fireside chats, presentations and 1x1 meetings, including activities highlighted by Wells Fargo, Citi, Morgan Stanley and others. Cabaletta Bio detailed investor-side engagements across Wells Fargo’s 21st Annual Healthcare Conference, the Cantor Global Healthcare Conference, Morgan Stanley’s Global Healthcare Conference, and the H.C. Wainwright Global Investment Conference, featuring meetings and fireside chats. Jade Biosciences disclosed one-on-one investor meetings and live webcasts with Wells Fargo, Citi and related fireside chats, with archived replays available afterward. These companies collectively underscore a busy September slate for biotech firms seeking to engage investors and accelerate advancement of their autoimmune-focused therapies and platforms.